Deep eutectic solvents (DES), prepared from choline chloride (ChCl) compound as hydrogen bond acceptor and lactic acid (LA), oxalic acid (OA), potassium hydroxide or urea (UA) as the electrostatic ...attracting donors in different amount ratios, were synthetized, applied and studied for lignocellulosic biomass fractionation. The mixtures of ChCl with OA or KOH were found to dissolve beech wood polymers more effectively compared to ChCl with LA or UA. In addition to DES screening test experiments, the influences of the process performance parameters, like measurement reaction time (2–24 h), temperature (60–100 °C) and the chip to solution mass relationship (1:100–1:10), on particle size distribution, solid residue's properties, functional cellulose, hemicellulose and lignin contents, the concentration of sugars, polyphenolics and volatile chemical products in raw liquid extract, as well as kinetics were experimentally determined. The further spectroscopic, microscopic and chromatographic analysis of solubilisation demonstrated that ChCl with OA selectively isolated phenols, could potentially be scalable and could be utilized in lignin-first bio-refinery plant. Purified cellulose-rich material was obtained, according to attenuated total reflection Fourier-transform infrared spectroscopy (ATR-FTIR), while polyphenols were above 15 g L−1 (gallic acid equivalent, examined by Folin–Ciocalteu method), revealing predominant dissolution. Conversely, for ChCl with KOH, aromatics were below detection limit value, while polysaccharides dropped for a factor of 10, paralleled to sawdust's fresh sample. The DES recovery by centrifugation, anti-solvent-assisted phase separation and vacuum distillation operation was also performed. While promising, NADES must be additionally developed, especially considering recycling, stability and economics.
Display omitted
•Dissolution and selective fraction of biomass using deep eutectic solvents.•FBRM analysis confirm the dissolution of biomass to particles of 10 μm size.•Characterization of biomass before and after (residue) fractionation – FTIR, SEM.•Confirmation of selective fractionation of biomass from solid and liquid fraction.•Polyphenolic content in liquid fraction confirms lignin extraction with ChCl: OA.
Intussusception in adult patient is rare. Gastroduodenal intussusception due to the gastrointestinal stromal tumors is infrequently described in the literature. Authors present a case of ...gastroduodenal intussusception due to the low-risk gastrointestinal stromal tumor of the lesser curvature of the gastric body with literature review.
Sixty-two-year-old male was admitted to our hospital with symptoms of acute gastric outlet obstruction. Imaging studies confirmed a lesion of the gastric wall producing gastroduodenal intussusception with pylorus obstruction. Upon laparotomy a tumor mass of the lesser curvature of the gastric body that invaginated through the pylorus into the duodenum was found. Desinvagination and resection of the tumor with the adequate resection margins were performed. Histology reveled a low-risk gastrointestinal stromal tumor. Due to favorable outcome only observation was suggested by the multidisciplinary team.
Gastroduodenal intussusception due to the gastrointestinal stromal tumor of the gastric wall is a rare event. Surgical resection is the treatment of choice. In selected cases laparosopic resection of the tumor can be performed.
The chemokine CCL5/RANTES is a versatile inflammatory mediator, which interacts with the receptor CCR5, promoting cancer cell interactions within the tumor microenvironment. Glioblastoma is a highly ...invasive tumor, in which CCL5 expression correlates with shorter patient survival. Using immunohistochemistry, we identified CCL5 and CCR5 in a series of glioblastoma samples and cells, including glioblastoma stem cells. CCL5 and CCR5 gene expression were significantly higher in a cohort of 38 glioblastoma samples, compared to low-grade glioma and non-cancerous tissues. The in vitro invasion of patients-derived primary glioblastoma cells and glioblastoma stem cells was dependent on CCL5-induced CCR5 signaling and is strongly inhibited by the small molecule CCR5 antagonist maraviroc. Invasion of these cells, which was enhanced when co-cultured with mesenchymal stem cells (MSCs), was inhibited by maraviroc, suggesting that MSCs release CCR5 ligands. In support of this model, we detected CCL5 and CCR5 in MSC monocultures and glioblastoma-associated MSC in tissue sections. We also found CCR5 expressing macrophages were in close proximity to glioblastoma cells. In conclusion, autocrine and paracrine cross-talk in glioblastoma and, in particular, glioblastoma stem cells with its stromal microenvironment, involves CCR5 and CCL5, contributing to glioblastoma invasion, suggesting the CCL5/CCR5 axis as a potential therapeutic target that can be targeted with repositioned drug maraviroc.